5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole

C110H87F6N29O6 — CID 158003857

IUPAC5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole
SMILESCCc1ccc(-c2noc(-c3nnn(-c4ccccc4F)c3-c3ccncc3)n2)cc1.CCc1ccc(-c2noc(-c3nnn(-c4ccccc4F)c3COC)n2)cc1.Fc1ccccc1-c1noc(-c2nnn(-c3ccccc3F)c2C2CCCC2)n1.Fc1ccccc1-n1nnc(-c2nc(-c3cccc(Cn4cccc4)c3)no2)c1-c1ccncc1.Fc1ccccc1-n1nnc(-c2nc(-c3cccnc3)no2)c1C1CCCC1
InChIInChI=1S/C26H18FN7O.C23H17FN6O.C21H17F2N5O.C20H17FN6O.C20H18FN5O2/c27-21-8-1-2-9-22(21)34-24(19-10-12-28-13-11-19)23(30-32-34)26-29-25(31-35-26)20-7-5-6-18(16-20)17-33-14-3-4-15-33;1-2-15-7-9-17(10-8-15)22-26-23(31-28-22)20-21(16-11-13-25-14-12-16)30(29-27-20)19-6-4-3-5-18(19)24;22-15-10-4-3-9-14(15)20-24-21(29-26-20)18-19(13-7-1-2-8-13)28(27-25-18)17-12-6-5-11-16(17)23;21-15-9-3-4-10-16(15)27-18(13-6-1-2-7-13)17(24-26-27)20-23-19(25-28-20)14-8-5-11-22-12-14;1-3-13-8-10-14(11-9-13)19-22-20(28-24-19)18-17(12-27-2)26(25-23-18)16-7-5-4-6-15(16)21/h1-16H,17H2;3-14H,2H2,1H3;3-6,9-13H,1-2,7-8H2;3-5,8-13H,1-2,6-7H2;4-11H,3,12H2,1-2H3
InChIKeyFEAYPOBXHSGVQQ-UHFFFAOYSA-N
MW2025.09 g/mol
LogP22.71
Rot. Bonds25

About 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole

5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole (PubChem CID 158003857) has the molecular formula C110H87F6N29O6 and a molecular weight of 2025.09 g/mol. Its IUPAC name is 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole.

Molecular Properties

Compound Name5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole
PubChem CID158003857
Molecular FormulaC110H87F6N29O6
Molecular Weight2025.09 g/mol
Exact Mass2023.73
IUPAC Name5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole
SMILESCCc1ccc(-c2noc(-c3nnn(-c4ccccc4F)c3-c3ccncc3)n2)cc1.CCc1ccc(-c2noc(-c3nnn(-c4ccccc4F)c3COC)n2)cc1.Fc1ccccc1-c1noc(-c2nnn(-c3ccccc3F)c2C2CCCC2)n1.Fc1ccccc1-n1nnc(-c2nc(-c3cccc(Cn4cccc4)c3)no2)c1-c1ccncc1.Fc1ccccc1-n1nnc(-c2nc(-c3cccnc3)no2)c1C1CCCC1
InChIInChI=1S/C26H18FN7O.C23H17FN6O.C21H17F2N5O.C20H17FN6O.C20H18FN5O2/c27-21-8-1-2-9-22(21)34-24(19-10-12-28-13-11-19)23(30-32-34)26-29-25(31-35-26)20-7-5-6-18(16-20)17-33-14-3-4-15-33;1-2-15-7-9-17(10-8-15)22-26-23(31-28-22)20-21(16-11-13-25-14-12-16)30(29-27-20)19-6-4-3-5-18(19)24;22-15-10-4-3-9-14(15)20-24-21(29-26-20)18-19(13-7-1-2-8-13)28(27-25-18)17-12-6-5-11-16(17)23;21-15-9-3-4-10-16(15)27-18(13-6-1-2-7-13)17(24-26-27)20-23-19(25-28-20)14-8-5-11-22-12-14;1-3-13-8-10-14(11-9-13)19-22-20(28-24-19)18-17(12-27-2)26(25-23-18)16-7-5-4-6-15(16)21/h1-16H,17H2;3-14H,2H2,1H3;3-6,9-13H,1-2,7-8H2;3-5,8-13H,1-2,6-7H2;4-11H,3,12H2,1-2H3
InChIKeyFEAYPOBXHSGVQQ-UHFFFAOYSA-N
XLogP22.71
TPSA400.98 Ų
H-Bond Donors
H-Bond Acceptors35
Rotatable Bonds25
Heavy Atoms151
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002025.09
LogP ≤ 522.71
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1035

Analyze 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole?
The IUPAC name of 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole (CID 158003857) is 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole.
What is the SMILES notation for 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole?
The canonical SMILES for 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole is CCc1ccc(-c2noc(-c3nnn(-c4ccccc4F)c3-c3ccncc3)n2)cc1.CCc1ccc(-c2noc(-c3nnn(-c4ccccc4F)c3COC)n2)cc1.Fc1ccccc1-c1noc(-c2nnn(-c3ccccc3F)c2C2CCCC2)n1.Fc1ccccc1-n1nnc(-c2nc(-c3cccc(Cn4cccc4)c3)no2)c1-c1ccncc1.Fc1ccccc1-n1nnc(-c2nc(-c3cccnc3)no2)c1C1CCCC1.
What is the InChIKey of 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole?
The InChIKey is FEAYPOBXHSGVQQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H18FN7O.C23H17FN6O.C21H17F2N5O.C20H17FN6O.C20H18FN5O2/c27-21-8-1-2-9-22(21)34-24(19-10-12-28-13-11-19)23(30-32-34)26-29-25(31-35-26)20-7-5-6-18(16-20)17-33-14-3-4-15-33;1-2-15-7-9-17(10-8-15)22-26-23(31-28-22)20-21(16-11-13-25-14-12-16)30(29-27-20)19-6-4-3-5-18(19)24;22-15-10-4-3-9-14(15)20-24-21(29-26-20)18-19(13-7-1-2-8-13)28(27-25-18)17-12-6-5-11-16(17)23;21-15-9-3-4-10-16(15)27-18(13-6-1-2-7-13)17(24-26-27)20-23-19(25-28-20)14-8-5-11-22-12-14;1-3-13-8-10-14(11-9-13)19-22-20(28-24-19)18-17(12-27-2)26(25-23-18)16-7-5-4-6-15(16)21/h1-16H,17H2;3-14H,2H2,1H3;3-6,9-13H,1-2,7-8H2;3-5,8-13H,1-2,6-7H2;4-11H,3,12H2,1-2H3.
What are the key properties of 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole?
5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole has a molecular weight of 2025.09 g/mol, XLogP of 22.71, 25 rotatable bonds, 0 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-(2-fluorophenyl)-1,2,4-oxadiazole;5-[5-cyclopentyl-1-(2-fluorophenyl)triazol-4-yl]-3-pyridin-3-yl-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-(methoxymethyl)triazol-4-yl]-1,2,4-oxadiazole;3-(4-ethylphenyl)-5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-1,2,4-oxadiazole;5-[1-(2-fluorophenyl)-5-pyridin-4-yltriazol-4-yl]-3-[3-(pyrrol-1-ylmethyl)phenyl]-1,2,4-oxadiazole is sourced from PubChem (CID 158003857), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).